MY146796A - Aminoindazole derivatives as medicaments and pharmaceutical compositions including them - Google Patents
Aminoindazole derivatives as medicaments and pharmaceutical compositions including themInfo
- Publication number
- MY146796A MY146796A MYPI20033345A MYPI20033345A MY146796A MY 146796 A MY146796 A MY 146796A MY PI20033345 A MYPI20033345 A MY PI20033345A MY PI20033345 A MYPI20033345 A MY PI20033345A MY 146796 A MY146796 A MY 146796A
- Authority
- MY
- Malaysia
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- medicaments
- nr8r9
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO NOVEL DERIVATIVES OF GENERAL FORMULA (I) IN WHICH R3 IS A (1-6C) ALKYL, ARYL, ARYL(1-6C)ALKYL, HETEROARYL, HETEROARYL(1-6C)ALKYL, ARYL OR HETEROARYL FUSED TO A (1-10C)CYCLOALKYL, HETEROCYCLE, HETEROCYCLOALKYL, CYCLOALKYL, ADAMANTYL, POLYCYCLOALKYL, ALKENYL, ALKYNYL, CONR1R2, COOR1, SO2R1, C(=NH)R1 OR C(=NH)NR1 RADICAL; R5 AND R6 ARE, INDEPENDENTLY OF ONE ANOTHER, CHOSEN FROM THE FOLLOWING RADICALS: HALOGEN , CN, NO2, NH2, OH, COOH, C(O)OR8, ?O?C(O)R8, NR8R9, NHC(O)R8, C(O)NR8R9, NHC(S)R8, C(S)NR8R9, SR8, S(O)R8, SO2 R8, NHSO2R8, SO2NR8R9, ?O?SO2R8, ?SO2?O?R8, TRIFLUOROMETHYL, TRIFLUOROMETHOXY, (1-6C)ALKYL, (1-6C)ALKOXY, ARYL , ARYL(1-6C) ALKYL, HETEROARYL, HETEROARYL(1-6C)ALKYL, HETEROCYCLE, CYCLOALKYL, ALKENYL, ALKYNYL, ADAMANTYL OR POLYCYCLOALKYL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0210962A FR2844267B1 (en) | 2002-09-05 | 2002-09-05 | NOVEL DERIVATIVES OF AMINOINDAZOLES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
Publications (1)
Publication Number | Publication Date |
---|---|
MY146796A true MY146796A (en) | 2012-09-28 |
Family
ID=31725841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20033345A MY146796A (en) | 2002-09-05 | 2003-09-04 | Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
Country Status (9)
Country | Link |
---|---|
CN (1) | CN1982316A (en) |
AR (1) | AR041131A1 (en) |
FR (1) | FR2844267B1 (en) |
ME (1) | MEP25708A (en) |
MY (1) | MY146796A (en) |
PE (1) | PE20040995A1 (en) |
RS (1) | RS52767B (en) |
TW (2) | TWI353978B (en) |
ZA (1) | ZA200501427B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007002717A1 (en) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
DE102007022565A1 (en) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001291013A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
HUP0400908A3 (en) * | 2000-12-21 | 2010-03-29 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them |
-
2002
- 2002-09-05 FR FR0210962A patent/FR2844267B1/en not_active Expired - Fee Related
-
2003
- 2003-09-01 PE PE2003000885A patent/PE20040995A1/en not_active Application Discontinuation
- 2003-09-03 RS YU20050165A patent/RS52767B/en unknown
- 2003-09-03 AR ARP030103186A patent/AR041131A1/en unknown
- 2003-09-03 CN CNA2007100042108A patent/CN1982316A/en active Pending
- 2003-09-03 ME MEP-257/08A patent/MEP25708A/en unknown
- 2003-09-04 MY MYPI20033345A patent/MY146796A/en unknown
- 2003-09-04 TW TW092124408A patent/TWI353978B/en not_active IP Right Cessation
- 2003-09-04 TW TW096144479A patent/TWI353245B/en not_active IP Right Cessation
-
2005
- 2005-02-17 ZA ZA200501427A patent/ZA200501427B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200501427B (en) | 2006-04-26 |
RS20050165A (en) | 2007-08-03 |
TW200413325A (en) | 2004-08-01 |
TWI353245B (en) | 2011-12-01 |
FR2844267B1 (en) | 2008-02-15 |
TWI353978B (en) | 2011-12-11 |
AR041131A1 (en) | 2005-05-04 |
RS52767B (en) | 2013-10-31 |
MEP25708A (en) | 2010-06-10 |
FR2844267A1 (en) | 2004-03-12 |
PE20040995A1 (en) | 2005-01-28 |
TW200820967A (en) | 2008-05-16 |
CN1982316A (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY138269A (en) | Aminoindazole derivatives, preparation process and intermediates of this process as medicinal products, and pharmaceutical compositions containing them | |
BR0314098A (en) | Aminoindazole derivatives as medicines and pharmaceutical compositions containing them | |
HUP0301113A2 (en) | Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors, pharmaceutical compositions containing them and their use | |
HUP0101204A2 (en) | Hiv inhibiting pyrimidine derivatives and pharmaceutical compositions containing them | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
HUP0002493A2 (en) | Use of colchinol derivatives as vascular damaging agents and certain new compounds | |
HUP0300203A2 (en) | Novel cyclic amide derivatives, and pharmaceutical compositions containing same | |
ATE381537T1 (en) | FORMANILIDE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS | |
AR079541A1 (en) | SUBSTITUTED COMPOUNDS OF N- (1H-INDAZOL-4-IL) IMIDAZO (1,2-A) PIRIDIN-3-CARBOXAMIDE AS CFMS INHIBITORS | |
CY1111075T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING THE PRODUCTS OF 3-AMINO-AZETIDINE, THEIR NEW PRODUCTS, AND THEIR PREPARATION | |
CA2437524A1 (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
HUP0400384A2 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
HUP0303458A2 (en) | 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them | |
NO20070557L (en) | Phthalazine derivatives as PARP inhibitors | |
HUP0203316A2 (en) | Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
CA2445190A1 (en) | Indole, azaindole and related heterocyclic amidopiperazine derivatives | |
NO20056192L (en) | Capase inhibitors and their use | |
HUP0002353A2 (en) | 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phoshodiesterase iv inhibitory activity and pharmaceutical compositions containing them | |
NO20070258L (en) | Benzyltriazolone Compounds as Non-Nucleoside Reverse Transcriptase Inhibitors | |
HUP0000914A2 (en) | Atropisomers of 3-aryl-4(3h)-quinazolinones and pharmaceutical compositions containing them | |
RU2007143512A (en) | IMIDAZO [1,2-a] PYRIDINE DERIVATIVES WHICH CAN BE USED AS PEPTIDDEFORMYLASE INHIBITORS | |
RS111104A (en) | 1-/(indol-3-yl)carbonyl/piperazine derivatives | |
ATE482933T1 (en) | SULFOPYRROL DERIVATIVES | |
MY146796A (en) | Aminoindazole derivatives as medicaments and pharmaceutical compositions including them | |
MY138085A (en) | Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |